Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the “Pure Global“) an integrated, growth-oriented life sciences and consumer products cannabis company, operating through its wholly-owned subsidiary PureSinse Inc. (“PureSinse” or “Company”), and Emerald Plants Health Source (OCTQB: STNN: EPHS Holdings Inc.) (“EPHS“) are pleased to announce that the companies have entered into a memorandum of understanding (“MOU“) through which the parties shall seek to enter into a cannabis wholesale supply agreement (“Supply Agreement“) whereby PureSinse will purchase 1,000 kg of dried flower from EPHS. The total quantity will be shipped periodically throughout a 12-month period commencing on or about July 2019 , as product becomes available.

Since obtaining its sales license last month PureSinse has been focused on securing high quality, differentiated inputs. The Supply Agreement will allow the Company to expand its product offerings to medical patients, support product demands from Spark Cannabis Clinic, and diversify its consumer channel strategy with adult use products. Further details will be provided upon the parties entering into a definitive supply agreement. There can be no assurance that a definitive supply agreement will be executed.

EPHS is located in downtown Montreal . By focusing on the development of unique genetics, a distinct cultivation methodology and a commitment to quality, EPHS intends to establish itself as a premium ‘craft’ producer.

“We are continuously looking for ways to get the highest quality products for distribution to our clinics, patients, and our online customers. This collaborative, forward-looking arrangement between PureSinse and EPHS meets a shared goal and vision; to deliver outstanding cannabis products to the sector” says Malay Panchal, President and CEO of Pure Global. “With their decades growing experience coupled with meeting Health Canada requirements, we anticipate that EPHS’ production method will produce wholesale supply that meets our quality policy.”

PureSinse has been recording revenues from its online sales that will be reported in its first-quarter earnings. The Company will continue to seek to secure supply in order to meet the anticipated demands of its customers in advance of Q3 2019, which is when sales from its Company’s Brampton facility are expected to commence.

“We are thrilled to be supplying PureSinse with our ‘Craft Grown with Care’ cannabis from our downtown Montreal facility. The firming of this relationship is a testament to our cultivation process, and the team behind it,” says Steven Perry , President of EPHS. “The team at Pure Global aligns with our mission and vision to provide the medical and adult-use markets with the highest quality craft dried flower possible.”

About Pure Global Cannabis

Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an innovation-based cannabis company led by experienced pharma, biotechnology, horticultural, and consumer packaged goods (CPG) experts. The company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act. The company’s Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. Pure Global will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, craft, and recreational legal markets with uniquely formulated and purified concentrates and dried flower. The company is using the Canadian market as a springboard to develop and manufacture GMP-compliant premium quality cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.